Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Convertible Debt (2022 - 2023)

Envoy Medical's Convertible Debt history spans 2 years, with the latest figure at $2.5 million for Q4 2023.

On a quarterly basis, Convertible Debt fell 92.51% to $2.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $2.5 million, a 92.51% decrease, with the full-year FY2023 number at $2.5 million, down 92.51% from a year prior.
Convertible Debt hit $2.5 million in Q4 2023 for Envoy Medical, down from $4.0 million in the prior quarter.
Over the last five years, Convertible Debt for COCH hit a ceiling of $33.4 million in Q4 2022 and a floor of $2.5 million in Q4 2023.